文献速递免疫规划

2016年4月至10月美国关联太平洋岛屿2岁儿童疫苗接种覆盖率

Vaccination Coverage Among Children Aged 2 Years - U.S. Affiliated Pacific Islands, April-October, 2016.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2018-05-25

2016年,CDC与五个美国关联太平洋岛屿(USAPI)的免疫规划项目试点使用病历摘录法估算2岁儿童疫苗接种覆盖率,这是首次在五个辖区同步评估。除帕劳外,所有辖区各疫苗推荐系列完成率均低于90%,六疫苗全程系列覆盖率从19.5%(丘克)至69.1%(帕劳)。在马绍尔群岛和丘克,外岛多数疫苗覆盖率低于主岛,差异为0.9至66.8个百分点。

要点

  • 除帕劳外,所有辖区各疫苗推荐系列完成率均低于90%。
  • 六疫苗全程系列(4:3:1:3:3:4)覆盖率从19.5%(丘克)至69.1%(帕劳)。
  • 马绍尔群岛和丘克外岛多数疫苗覆盖率低于主岛,差异为0.9至66.8个百分点。

核心结论

  • 病历摘录法可快速评估疫苗接种覆盖率并及时传播结果以指导项目决策。
  • 有效监测疫苗接种覆盖率并实施数据驱动干预,对维持区域和美国本土免受疫苗可预防疾病暴发保护至关重要。

研究设计与样本

  • 2016年,USAPI免疫规划项目与CDC试点使用病历摘录法估算2岁儿童疫苗接种覆盖率。
  • 这是首次在五个USAPI辖区(美属萨摩亚、密克罗尼西亚联邦丘克州、北马里亚纳群岛联邦、马绍尔群岛共和国和帕劳共和国)同步评估儿童疫苗接种覆盖率。
  • 在数据充足的两个辖区评估了主岛与外岛之间的疫苗接种覆盖率差异。

主要发现

  • 除帕劳外,所有辖区各疫苗推荐系列完成率均低于90%。
  • 六疫苗全程系列(4:3:1:3:3:4)覆盖率从19.5%(丘克)至69.1%(帕劳)。
  • 在马绍尔群岛和丘克,外岛多数疫苗覆盖率低于主岛,差异为0.9至66.8个百分点。

关键数值与推荐

  • 系列覆盖率包括:≥4剂百白破(DTaP)、≥3剂脊灰灭活疫苗(IPV)、≥1剂麻腮风(MMR)、≥3剂b型流感嗜血杆菌(Hib)疫苗、≥3剂乙肝(HepB)疫苗、≥4剂肺炎球菌结合疫苗(PCV),即4:3:1:3:3:4。
  • 还评估了≥3剂轮状病毒疫苗覆盖率。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Vaccine-preventable diseases (VPDs) cause substantial morbidity and mortality in the United States Affiliated Pacific Islands (USAPI).* CDC collaborates with USAPI immunization programs to monitor vaccination coverage. In 2016, † USAPI immunization programs and CDC piloted a method for estimating up-to-date status among children aged 2 years using medical record abstraction to ascertain regional vaccination coverage. This was the first concurrent assessment of childhood vaccination coverage across five USAPI jurisdictions (American Samoa; Chuuk State, Federated States of Micronesia [FSM]; Commonwealth of the Northern Mariana Islands [CNMI]; Republic of the Marshall Islands [RMI]; and Republic of Palau).§ Differences in vaccination coverage between main and outer islands¶ were assessed for two jurisdictions where data were adequate.** Series coverage in this report includes the following doses of vaccines: ≥4 doses of diphtheria and tetanus toxoids and acellular pertussis vaccine (DTaP); ≥3 doses of inactivated poliovirus vaccine (IPV); ≥1 dose of measles, mumps, and rubella vaccine (MMR); ≥3 doses of Haemophilus influenzae type B (Hib) vaccine; ≥3 doses of hepatitis B (HepB) vaccine; and ≥4 doses of pneumococcal conjugate vaccine (PCV); i.e., 4:3:1:3:3:4. Coverage with ≥3 doses of rotavirus vaccine was also assessed. Completion of the recommended series of each of these vaccines†† was <90% in all jurisdictions except Palau. Coverage with the full recommended six-vaccine series (4:3:1:3:3:4) ranged from 19.5% (Chuuk) to 69.1% (Palau). In RMI and Chuuk, coverage was lower in the outer islands than in the main islands for most vaccines, with differences ranging from 0.9 to 66.8 percentage points. Medical record abstraction enabled rapid vaccination coverage assessment and timely dissemination of results to guide programmatic decision-making. Effectively monitoring vaccination coverage, coupled with implementation of data-driven interventions, is essential to maintain protection from VPD outbreaks in the region and the mainland United States.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Tippins A, Murthy N, Meghani M, et al. Vaccination Coverage Among Children Aged 2 Years - U.S. Affiliated Pacific Islands, April-October, 2016. MMWR Morb Mortal Wkly Rep. 2018. PMID: 29795077. doi:10.15585/mmwr.mm6720a3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。